BioLight Life Sciences Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was ILS 0.034 million compared to ILS 0.006 million a year ago. Net loss was ILS 19.03 million compared to net income of ILS 2.27 million a year ago.

Basic loss per share from continuing operations was ILS 4.11 compared to basic earnings per share from continuing operations of ILS 0.5 a year ago. Diluted loss per share from continuing operations was ILS 4.11 compared to diluted earnings per share from continuing operations of ILS 0.5 a year ago.